"Another strong randomized controlled trial has shown early ivermectin use failed to reduce Covid-19 hospitalizations. The New England Journal of Medicine published the results of the trial, which covered 1400 patients in Brazil. The trial was double-blinded and randomized, the gold standard. The trial also failed to show that ivermectin had any impact on Covid-19 deaths."
Designed to fail:
"Here is a picture of the 'Too Little Too Late' principle. The study was designed by the authors, to fail. The effect arrived after blood clotting had already taken hold in the lungs - forcing hospitalization. Blue shows what they should have tested."
"If this study had been done in May 2020, on a limited budget and with limited domain intelligence, I still would not like it. However, to publish a study this flawed in its design, this late into the process - is criminal. Crap like this has destroyed public trust in science."
Comments